14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 ADCT stock ended at $4.83. This is 8.54% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 13.66% from a day low at $4.32 to a day high of $4.91.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Adc Therapeutics Ltd prices

Date Open High Low Close Volume
May 07, 2024 $4.40 $4.91 $4.32 $4.83 883 500
May 06, 2024 $4.82 $5.15 $4.42 $4.45 3 326 556
May 03, 2024 $4.96 $5.11 $4.81 $4.90 323 018
May 02, 2024 $4.74 $4.74 $4.42 $4.73 266 955
May 01, 2024 $4.44 $4.85 $4.35 $4.71 398 497
Apr 30, 2024 $4.47 $4.58 $4.35 $4.41 218 664
Apr 29, 2024 $4.37 $4.73 $4.30 $4.50 242 020
Apr 26, 2024 $4.44 $4.51 $4.21 $4.34 321 167
Apr 25, 2024 $4.65 $4.65 $4.41 $4.44 295 796
Apr 24, 2024 $4.99 $5.00 $4.71 $4.78 276 553
Apr 23, 2024 $4.72 $5.08 $4.72 $4.97 401 770
Apr 22, 2024 $4.79 $4.79 $4.56 $4.68 173 365
Apr 19, 2024 $4.76 $4.92 $4.60 $4.72 319 668
Apr 18, 2024 $4.95 $4.95 $4.72 $4.76 261 096
Apr 17, 2024 $4.52 $5.02 $4.49 $4.96 1 226 234
Apr 16, 2024 $4.33 $4.60 $4.30 $4.44 208 669
Apr 15, 2024 $4.39 $4.47 $4.11 $4.37 460 562
Apr 12, 2024 $4.71 $4.75 $4.31 $4.39 336 469
Apr 11, 2024 $4.77 $4.86 $4.52 $4.68 401 412
Apr 10, 2024 $4.60 $4.79 $4.50 $4.71 359 777
Apr 09, 2024 $5.14 $5.31 $4.75 $4.78 436 488
Apr 08, 2024 $5.02 $5.35 $4.93 $5.09 614 231
Apr 05, 2024 $4.64 $5.19 $4.45 $5.00 750 767
Apr 04, 2024 $4.44 $4.96 $4.36 $4.71 768 948
Apr 03, 2024 $4.34 $4.44 $4.25 $4.43 321 477
Click to get the best stock tips daily for free!

About Adc Therapeutics Ltd

Adc Therapeutics Ltd ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second... ADCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT